Characterization and strong risk association of TLR2 del -196 to -174 polymorphism and Helicobacter pylori and their influence on mRNA expression in gastric cancer-Reference-Cited by-同舟云学术

Characterization and strong risk association of TLR2 del -196 to -174 polymorphism and Helicobacter pylori and their influence on mRNA expression in gastric cancer

Published:2020-05-15 Issue:5 Volume:12 Page:535-548
ISSN:1948-5204
Container-title:World Journal of Gastrointestinal Oncology
language:
Short-container-title:WJGO

Author:

Lourenço Caroline de Matos,Susi Manoela Dias,Nascimento Mariah Cristina Antunes do,Junior Vilson Serafim,Vila Ana Paula Simedan,Rodrigues-Flemming Gabriela Helena,Goloni-Bertollo Eny Maria,Silva Ana Elizabete,Oliveira-Cucolo Juliana Garcia de

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,Oncology

Reference42 articles.

1. Correa P. A human model of gastric carcinogenesis. Cancer Res 1988; 48: 3554-3560

2. Premalignant lesions and gastric cancer: Current understanding

3. (IARC) IAfRoC. Schistossomes, liver flukes and Helicobacter pylori. Lyon, 1994

4. Dysbiosis Disrupts Gut Immune Homeostasis and Promotes Gastric Diseases

5. The Relationship between Toll-like Receptors andHelicobacter pylori-Related Gastropathies: Still a Controversial Topic

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Common variants in toll-like receptor family genes and risk of gastric cancer: a systematic review and meta-analysis;Frontiers in Genetics;2023-11-28

2. Salivary IL‐33 and sST2 levels in relation to TLR2 rs111200466 polymorphism and periodontitis;Oral Diseases;2023-07-10

3. The TLR/MyD88 signalling cascade in inflammation and gastric cancer: the immune regulatory network of Helicobacter pylori;Journal of Molecular Medicine;2023-05-17

4. Association of Toll‐like receptor 2 rs111200466 polymorphism with low serum levels of IL‐33 in early childhood;APMIS;2023-04-13

5. Synonymous Variants: Necessary Nuance in Our Understanding of Cancer Drivers and Treatment Outcomes;JNCI: Journal of the National Cancer Institute;2022-04-27